Work

Terlipressin-Associated Complete Heart Block

Year: 2025

Type: article

Abstract: Terlipressin has been recently approved in the United States to treat hepatorenal syndrome, a feared complication of both acute and chronic liver diseases. Side effects of the medication have been studied through clinical trials and the precedent use in Europe, as well as extrapolation from its analog vasopressin. As its use is becoming more prevalent, unforeseen complications have arisen. We report a case of complete heart block associated with terlipressin use in presumed hepatorenal syndrome in acute liver injury.

Source: ACG Case Reports Journal

DOI: 10.14309/crj.0000000000001654

Authors: Jiunn Song, Tristan Alfie, E. Kevin Heist, Raymond T. Chung

Institution: Massachusetts General Hospital

Language: English

Topic: Liver Disease and Transplantation

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4409124237

FWCI: 0.497

Cites: 20

Cited by: 1

Related to: 10